Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: Commercial kit evaluation and validation to support pharmacokinetic studies

Journal of Pharmaceutical and Biomedical Analysis

Volumn 42, Issue 2, 2006, Pages 261-271

  Sukovaty, Richard L ^a   Lee, Jean W ^a   Fox, John ^b   Toney, Karen ^b   Papac, Damon I ^b   Grover, Thomas A ^b   Wells, David S ^b  

^a MDS Inc   (Canada)

^b NPS Pharmaceutical Inc   (United States)

Author keywords

Commercial kit; GLP bioanalysis; Human parathyroid hormone; Immunoassays; PTH; Recombinant peptide drug

Indexed keywords

ANTIBODY; EDETIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[3-84]; PARATHYROID HORMONE[7-84]; RECOMBINANT PARATHYROID HORMONE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BIOCHEMICAL EQUIPMENT; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; IMMUNOLUMINOMETRIC ASSAY; IMMUNORADIOMETRIC ASSAY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

DRUG STABILITY; DRUG STORAGE; HUMANS; IMMUNORADIOMETRIC ASSAY; PARATHYROID HORMONE; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; RECOMBINANT PROTEINS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33747763334     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.04.023     Document Type: Article

References (27)

1. Brown E.M. In: Belezikian J.P., Marcus, and Levine (Eds). The Parathyroids (1994), Raven Press, New York 15-54
2. Fitzpatrick L.A., and Bilezikian J.P. In: Belezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology (1996), Academic Press, San Diego 339-346
3. Habener J.F., and Potts Jr. J.T. New Engl. J. Med. 299 (1978) 580-585 635-644
4. Finkelstein J.S. In: Belezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology (1996), Academic Press, San Diego 993-1006
5. Tam C.S., Heersche J.N., Murray T.M., and Parsons J.A. Endocrinology 110 (1982) 506-512
6. Raisz L.G., Yajnik C.H., Bockman R.S., and Bower B.F. Ann. Intern. Med. 91 (1979) 739-740
7. Andress D.L., Endres D.B., Ott S.M., and Sherrard D.J. Kidney Int. Suppl. 18 (1986) s87-s90
8. Wood W.G., Butz R., Casaretto M., Hehrmann R., Juppner H., Marschner I., Wachter C., Zahn H., and Hesch R.D. J. Clin. Chem. Biochem. 18 (1980) 789-795
9. Kao P.C., Jiang N.S., Klee G.G., and Purnell D.C. Clin. Chem. 28 (1982) 69-74
10. Segre G.V., and Potts Jr. J.T. In: Degroot L.J. (Ed). Endocrinology (1995), W.B. Saunders, Philadelphia 1075-1093
11. Potts Jr. J.T., Bringhurst F.R., Gardella T.J., Nussbaum S.R., Segre G.V., and Kronenberg H.M. In: Degroot L.J. (Ed). Endocrinology (1996), W.B. Saunders, Philadelphia 920-965
12. Nussbaum S.R., Zahradnik R.J., Lavigne J.R., Brennan G.L., Nozawa-Ung K., Kim L.Y., Keutmann H.T., Wang W.A., Potts Jr. J.T., and Segre G.V. Clin. Chem. 33 (1987) 1364-1367
13. Brown R.C., Aston J.P., Weeks I., and Woodhead J.S. J. Clin. Endocrinol. Metab. 65 (1987) 407-414
14. Intact PTH Directional Insert, Nichols Institute Diagnostics, kit insert, #36T-2170.
15. DeSilva B., Smith W., Weiner R., Kelley M., Smolec J., Lee B., Khan M., Tacey D., Hill H., and Celniker A. Pharm. Res. 20 (2003) 1885-1900
16. Lepage R., Roy L., Brossard J.H., Rousseau L., Dorais C., Lazure C., and D'Amour P. Clin. Chem. 44 (1998) 805-809
17. John M.R., Goodman W.G., Gao P., Cantor T., Salusky I., and Juppner H. J. Clin. Endocrinal. Metab. 84 (1999) 4287-4290
18. Gao P., Scheibel S., D'Amour P., John M., Rai S., Schmidt-Gayk H., and Cantor T. J. Bone Miner. Res. 16 (2001) 605-614
19. Brossard J., Lepage R., Cardinal H., Roy L., Rousseau L., Dorais C., and D'Amour P. Clin. Chem. 46 (2000) 697-703
20. Murray T.M., Rao L.G., Divieti P., and Bringhurst F.R. Endocr. Rev. 26 (2005) 78-113
21. Federal Register 57 FR 7002, (1992).
22. Federal Register 42 CFR part 493, (2003).
23. Guidance for industry on bioanalytical method validation: availability. Federal Reg., (2001).
24. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittamn K.A., and Spector S. J. Pharm. Sci. 81 (1992) 309-312
25. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551-1557
26. Findlay J.W.A., Smith W.C., Lee J.W., et al. J. Pharm. Biomed. Anal. 21 (2000) 1249-1273
27. Miller K., Bowsher R.R., Celniker A., Gibbons J., Gupta S., Lee J.W., Swanson S.J., Smith W.C., and Weiner R.S. Pharm. Res. 18 (2001) 1373-1383